Basal-like breast cancer (BLBC) or triple-negative breast cancer (TNBC) is characterized by a lack of hormone receptors (estrogen receptor and progesterone receptor) and high expression or amplification of human epidermal growth factor receptor 2 (HER2) [1, 2]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.